E Cannabis Central: MediPharm Labs Shows Impressive Q2 Performance On All Fronts - Stock Still Falls 16%

This Q2 financial report substantiates the CEO's comments above suggesting that MediPharm Labs may well continue its impressive performance on all fronts for the foreseeable future.

1 2 3
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.